VELDURIV
Live / Applied — First extension granted (statement of use) (as of 15 Jan 2026)
What this means for you
Not registered yet, but its 22 Jan 2021 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90482819
- Mark type
- Stylized text
- Filed
- 22 Jan 2021
- Published for opposition
- 03 Jun 2025
- Attorney of record
- Brent Johnson
Goods and services
- Class 005 — Pharmaceuticals: Prescription medicines for the treatment of migraines
Owner
- Axsome Therapeutics, Inc., New York, NY, US
- Axsome Therapeutics, Inc., New York, NY, US
Prosecution history
- 15 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Jan 2026 — SOU EXTENSION 1 GRANTED
- 14 Jan 2026 — SOU EXTENSION 1 FILED
- 14 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 30 Sept 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 18 Sept 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 18 Sept 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 18 Sept 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 03 Jun 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Jun 2025 — PUBLISHED FOR OPPOSITION
- 28 May 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 02 May 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 02 May 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 02 May 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 02 May 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED